Reunion Neuroscience Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Reunion Neuroscience Inc. - overview
Established
2022
Location
Toronto, ON, Canada
Primary Industry
Biotechnology
About
Founded in 2022 and based in Ontario, Canada, Reunion Neuroscience Inc. , operates as a clinical-stage biopharmaceutical company that develops and patents therapeutic solutions for the mental health industry. In May 2023, MPM Capital agreed to acquire Reunion Neuroscience Inc. for USD 13.
1 million in cash or USD 1. 12 per share in a public-to-private transaction. As of 2023, the company is led by its president and CEO, Greg Mayes, and is listed on NASDAQ under the ticker symbol REUN. The company offers various pharmaceutical solutions that include novel psychedelic compounds used for the treatment of psychiatric conditions, including depression.
The serotonergic psychedelic compound is used to generate serotonergic receptors in the brain, regulating mood, appetite, sleep, learning, memory, and many other biological and physiological functions, hence acting as an antidepressant for patients. The company plans to get delisted from the NASDAQ stock exchange.
Current Investors
MPM BioImpact, Novo Holdings, Plaisance Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.reunionneuro.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Reunion Neuroscience Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public to Private | Completed | Reunion Neuroscience Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.